Neurocrine Biosciences had a net margin of 14.49% and a return on equity of 13.38%. Analysts anticipate that Neurocrine Biosciences will post 4.28 EPS for the current year.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The new indication brings the drug into direct competition with Ongentys from rival Neurocrine Biosciences, which was approved for the same use last year. Adamas noted that Gocovri (amantadine ...

Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial ...

An engineering student was stabbed to death while another was critically injured over a petty dispute at Saran’s Bhagwan Bazar police station area.

March 12, 2025 • With uncertainties around federal funding for higher education, some schools are cutting back. Experts say that could hurt not only students and faculty, but ultimately make the ...

The Elementary to Postsecondary Student Education Dashboard: Enrolments, Graduations and Tuition Fees comprehensive data visualization tool overviews counts of enrolments and graduations for ...

Old growth can be a renewable resource, too, if we preserve original forest and protect some of the resilient second growth, writes a former logger.